PIK3CB and neuroblastoma: The Akt activation in neuroblastoma proceeds in a PI3K-dependent manner, because the PI3K inhibitor LY294002 completely reversed the effects of the insulin-like growth factor–mediated activation of Akt and its protection of neuroblastoma cells from the apoptosis [39].